Noteworthy, in various metabolic disorders such as obesity, hyperlipidemia, diabetes, and metabolic dysfunction-associated steatotic liver disease, elevated serum FGF21 level were also recorded (Yang et al., 2023). Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.